These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22989581)

  • 1. Functional regeneration of the ex-vivo reconstructed mesocorticolimbic dopaminergic system.
    Dossi E; Heine C; Servettini I; Gullo F; Sygnecka K; Franke H; Illes P; Wanke E
    Cereb Cortex; 2013 Dec; 23(12):2905-22. PubMed ID: 22989581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
    Gale SD; Perkel DJ
    J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological characteristic of corticoaccumbens synapses in rat mesolimbic system reconstructed using organotypic slice cultures.
    Maeda T; Fukazawa Y; Shimizu N; Ozaki M; Yamamoto H; Kishioka S
    Brain Res; 2004 Jul; 1015(1-2):34-40. PubMed ID: 15223364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tonic or Phasic Stimulation of Dopaminergic Projections to Prefrontal Cortex Causes Mice to Maintain or Deviate from Previously Learned Behavioral Strategies.
    Ellwood IT; Patel T; Wadia V; Lee AT; Liptak AT; Bender KJ; Sohal VS
    J Neurosci; 2017 Aug; 37(35):8315-8329. PubMed ID: 28739583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y(1) receptor mediated neuronal fibre outgrowth in organotypic brain slice co-cultures.
    Heine C; Sygnecka K; Scherf N; Grohmann M; Bräsigk A; Franke H
    Neuropharmacology; 2015 Jun; 93():252-66. PubMed ID: 25683778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of ethanol action on midbrain dopaminergic neuron firing: a dynamic-clamp study of the role of I(h) and GABAergic synaptic integration.
    Tateno T; Robinson HP
    J Neurophysiol; 2011 Oct; 106(4):1901-22. PubMed ID: 21697445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medial prefrontal cortical output neurons to the ventral tegmental area (VTA) and their responses to burst-patterned stimulation of the VTA: neuroanatomical and in vivo electrophysiological analyses.
    Au-Young SM; Shen H; Yang CR
    Synapse; 1999 Dec; 34(4):245-55. PubMed ID: 10529719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra.
    Gervais J; Rouillard C
    Synapse; 2000 Mar; 35(4):281-91. PubMed ID: 10657038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast transmission from the dopaminergic ventral midbrain to the sensory cortex of awake primates.
    Mylius J; Happel MF; Gorkin AG; Huang Y; Scheich H; Brosch M
    Brain Struct Funct; 2015 Nov; 220(6):3273-94. PubMed ID: 25084746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine Transporter Is a Master Regulator of Dopaminergic Neural Network Connectivity.
    Miller DR; Guenther DT; Maurer AP; Hansen CA; Zalesky A; Khoshbouei H
    J Neurosci; 2021 Jun; 41(25):5453-5470. PubMed ID: 33980544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
    Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
    Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reelin and CXCL12 regulate distinct migratory behaviors during the development of the dopaminergic system.
    Bodea GO; Spille JH; Abe P; Andersson AS; Acker-Palmer A; Stumm R; Kubitscheck U; Blaess S
    Development; 2014 Feb; 141(3):661-73. PubMed ID: 24449842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat: Historical perspective.
    Figlewicz DP
    Brain Res; 2016 Aug; 1645():68-70. PubMed ID: 26731335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state.
    Brown MT; Henny P; Bolam JP; Magill PJ
    J Neurosci; 2009 Mar; 29(9):2915-25. PubMed ID: 19261887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
    Hether S; Misono K; Lessard A
    Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area.
    Reyes S; Fu Y; Double K; Thompson L; Kirik D; Paxinos G; Halliday GM
    J Comp Neurol; 2012 Aug; 520(12):2591-607. PubMed ID: 22252428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventral tegmental area/substantia nigra and prefrontal cortex rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: effect of neuroprotective agents.
    Colombo L; Parravicini C; Lecca D; Dossi E; Heine C; Cimino M; Wanke E; Illes P; Franke H; Abbracchio MP
    Neurochem Int; 2014 Jan; 66():43-54. PubMed ID: 24463100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.